about
Rational and timely haemostatic interventions following cardiac surgery - coagulation factor concentrates or blood bank products.Fibrinogen as a hemostatic agent.Transcatheter Aortic Valve Thrombosis: Incidence, Predisposing Factors, and Clinical Implications.The association between platelet transfusion and adverse outcomes after coronary artery bypass surgery.Abscess Formation after Septic Arthritis in the Sternoclavicular Joint of Two Healthy MenTransfusion of shed mediastinal blood reduces the use of allogenic blood transfusion without increasing complications.Transfusion of blood during cardiac surgery is associated with higher long-term mortality in low-risk patients.Temporal changes in clot lysis and clot stability following tranexamic acid in cardiac surgery.Cardiac surgery in patients with haemophilia.Reply to Petricevic et al.Antiplatelet therapy at the time of coronary artery bypass grafting: a multicentre cohort study.Fracturing the Ring of Small Mitroflow Bioprostheses by High-Pressure Balloon Predilatation in Transcatheter Aortic Valve-in-Valve Implantation.Early aortic transcatheter heart valve thrombosis: diagnostic value of contrast-enhanced multidetector computed tomography.Three-dimensional multidetector computed tomography versus conventional 2-dimensional transesophageal echocardiography for annular sizing in transcatheter aortic valve replacement: Influence on postprocedural paravalvular aortic regurgitation.Compromised cardiac function in exercising teenagers with pectus excavatum.Transcatheter mitral valve implantation via transapical approach: an early experienceNormalized Cardiopulmonary Exercise Function in Patients With Pectus Excavatum Three Years After OperationReply to Neviere et alImproved cardiopulmonary exercise function after modified Nuss operation for pectus excavatumTheragnostic performance of ex vivo testing of haemostatic intervention and clinical effect of recombinant factor VIIa and fibrinogen concentrate[Minimally invasive mitral valve surgery]
P50
Q33459212-53FE0016-AFDB-4311-98DC-C619E37838C7Q37998405-4E6E4DCE-0D64-4866-98DC-FAC651FA1C3CQ39435472-F5351E61-77CE-41B5-A96D-4707E3A77DD9Q40581170-6A22B996-5C81-4247-A047-87E4BD0D23A4Q40805979-20E5F93C-6663-4A08-88CA-108DEE5FDCA9Q44970929-B242C9BD-B8D4-4AB6-A047-21FAF7301A9CQ45516517-3B2F6D78-3135-4DA9-960F-DF76174EF470Q45858089-63127630-810F-436A-B428-7DD0B353F3BDQ45882853-EB399A09-E1FF-4266-A14C-3EC54105C468Q46610862-D2D21A2C-5C10-4215-8C1E-B5ADF90C7D49Q50855411-7D3B76A9-D992-4E3D-9828-C49855393DE7Q51835157-DBB25A8B-9371-4A2C-95CC-CECAAB05B3F5Q53015277-9AF9693E-1371-4D96-BC1E-E18D06E5DF39Q53108227-A5488DD0-E424-4B3F-8902-3D79166F15C8Q53211428-B7BF720C-7F9E-436A-BDB2-BBA1B884D58BQ60456366-9CE46B70-F995-4243-A2D2-251E97D36D5AQ60456385-72DD468E-DCD6-42B1-BA44-376D831B9FAFQ60456388-DF3B876A-927E-41BB-AD2D-8515911CA2C9Q60456391-E3956515-1DC8-4B7E-B699-3E0F83E57F72Q60456394-A8B19CF2-F337-4E9B-A9E6-EE98F7428B18Q60456406-E5FF2588-645A-471E-8ECD-E46F2C81D2A5
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mariann Tang
@ast
Mariann Tang
@en
Mariann Tang
@es
Mariann Tang
@nl
Mariann Tang
@sl
type
label
Mariann Tang
@ast
Mariann Tang
@en
Mariann Tang
@es
Mariann Tang
@nl
Mariann Tang
@sl
prefLabel
Mariann Tang
@ast
Mariann Tang
@en
Mariann Tang
@es
Mariann Tang
@nl
Mariann Tang
@sl
P106
P21
P31
P496
0000-0003-2861-682X